SCHEMBL4955792

SCHEMBL4955792

CCCc1nc2ccccc2c(=O)n1-c1ccc(NC(=O)O)cc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
BLM P54132 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
LMNA P02545 1/20 0.67
MAPK1 P28482 1/20 0.67
CYP1A2 P05177 1/20 0.66
CYP3A4 P08684 1/20 0.66
CYP2D6 P10635 1/20 0.66
CYP2C9 P11712 1/20 0.66
CYP2C19 P33261 1/20 0.66
PDE10A Q9Y233 7/20 0.61
USP2 O75604 1/20 0.57
TP53 P04637 1/20 0.56
ALDH1A1 P00352 2/20 0.55
KCNH2 Q12809 1/20 0.54
HRH3 Q9Y5N1 1/20 0.54
MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4957073 0.94 LMNA (0.77) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL4960948 0.93 MAPK1 (0.62) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL4956958 0.87 LMNA (0.72) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL14115045 0.86 MEN1 (0.61) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL28451012 0.85 MEN1 (0.78) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL4955797 0.84 LMNA (0.72) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL14115046 0.82 LMNA (0.66) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL4960332 0.82 LMNA (0.76) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL4959512 0.82 MEN1 (0.73) MEN1KMT2ABLMSMN1; SMN2LMNA
SCHEMBL4955782 0.81 LMNA (0.73) MEN1KMT2ABLMSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed